npj Parkinson's Disease, 2373-8057

Journal

More filtering options
  1. 2018
  2. Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

    Jonathan Timpka, Dahlström, Ö., Spreco, A., Maria H Nilsson, Susanne Iwarsson, Timpka, T. & Per Odin, 2018 Dec 12, In : npj Parkinson's Disease. 4, p. 1-5 36.

    Research output: Contribution to journalArticle

  3. Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics

    Standaert, D. G., Boyd, J. T., Per Odin, Robieson, W. Z., Zamudio, J. & Chatamra, K., 2018, In : npj Parkinson's Disease. 4, p. 1-6 4.

    Research output: Contribution to journalArticle

  4. Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease

    Per Odin, Chaudhuri, K. R., Volkmann, J., Antonini, A., Storch, A., Dietrichs, E., Pirtošek, Z., Henriksen, T., Horne, M., Devos, D. & Bergquist, F., 2018, In : npj Parkinson's Disease. 4, p. 1-7 14.

    Research output: Contribution to journalReview article

  5. 2017
  6. GFORCE-PD still going strong in 2016

    Malin Parmar, Takahashi, J., Studer, L. & Barker, R. A., 2017 Feb 23, In : NPJ Parkinson's Disease. 3, 16014.

    Research output: Contribution to journalReview article

  7. Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale

    Martinez-Martin, P., Manuel Rojo-Abuin, J., Rizos, A., Rodriguez-Blazquez, C., Trenkwalder, C., Perkins, L., Sauerbier, A., Per Odin, Antonini, A. & Chaudhuri, K. R., 2017, In : npj Parkinson's Disease. 3, p. 1-6 8.

    Research output: Contribution to journalArticle

  8. 2016
  9. Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease

    Fernandez, H. H., Robieson, W. Z., Chatamra, K., Dubow, J., Eaton, S., Benesh, J. A. & Per Odin, 2016, In : npj Parkinson's Disease. 2, p. 16015

    Research output: Contribution to journalArticle

  10. Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future

    Ray Chaudhuri, K., Qamar, M. A., Rajah, T., Loehrer, P., Sauerbier, A., Per Odin & Jenner, P., 2016, In : npj Parkinson's Disease. 2, p. 1-7 16023.

    Research output: Contribution to journalReview article